BioVigilant’s IMD™-A instruments employ a unique optical technology to continuously sample the air and warn immediately when microbial contamination is detected—screening for biological particles as small as 0.5 microns.  A continuous stream of real-time data enables constant monitoring and effective trending that could prevent excursions from leading to the catastrophic loss of a batch.  This level of monitoring and trending is not possible with conventional growth-based methods that delay results for 5-7 days.

By empowering proactive intervention, BioVigilant’s IMD systems can help pharmaceutical quality managers prevent the costly downtime and product loss that can result from the biological contamination of pharmaceutical manufacturing environments.  

In the event of an excursion, IMD instruments can help managers rapidly pinpoint the root cause of contamination using an on-board camera to correlate observed behavior and environmental data.  The instantaneous results speed both problem remediation and its verification.  IMD instruments also improve on existing methods by requiring minimal –if any– human intervention and no consumables, greatly reducing the direct costs of environmental testing.

Occupying 25 X 41 centimeters of counter space and weighing only 30 pounds, the compact design of the IMD-A 200-1 makes it easily portable for flexible use in many different environments.  The instrument offers a draw volume of 1.1 liters per minute, and includes a camera, notebook computer and BioVigilant’s PharmaMaster™ analysis and control software.